World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
59
Citations
11472
World Ranking
3442
National Ranking
130

Guido Antonelli publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Guido Antonelli sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 431 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Guido Antonelli D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Guido Antonelli sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 59 D-Index — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Guido Antonelli is affiliated with Sapienza University of Rome in Italy and has a substantial publication record primarily in the field of Medicine. Their research prominently focuses on Infectious Diseases, with additional work in Epidemiology, Oncology, Molecular Biology, and Surgery.

The main topics of their work include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Respiratory viral infections research
  • Antibiotic Resistance in Bacteria
  • SARS-CoV-2 detection and testing
  • Animal Virus Infections Studies
  • COVID-19 and healthcare impacts

Frequent publication venues for Guido Antonelli are:

  • Clinical Microbiology and Infection
  • Journal of Medical Virology
  • Microorganisms
  • Vaccines
  • Frontiers in Immunology

Notable recent papers include:

  • Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab, 2020, Journal of Endocrinological Investigation
  • Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19, 2020, Frontiers in Medicine
  • Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro, 2020, Pharmacological Research
  • Evolutionary Trajectories toward Ceftazidime-Avibactam Resistance in Klebsiella pneumoniae Clinical Isolates, 2021, Antimicrobial Agents and Chemotherapy
  • Interferon-β-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection, 2020, The Journal of Infectious Diseases

Frequent co-authors collaborating with Guido Antonelli include:

  • Carolina Scagnolari
  • Ombretta Turriziani
  • Claudio Maria Mastroianni
  • Federica Frasca
  • Alessandra Pierangeli

Best Publications

  • Respiratory syncytial virus, human bocavirus and rhinovirus bronchiolitis in infants

    Fabio Midulla;Carolina Scagnolari;Enea Bonci;Alessandra Pierangeli

  • Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab.

    D. Paoli;F. Pallotti;S. Colangelo;F. Basilico

  • Neutralizing antibodies to interferon-alpha: relative frequency in patients treated with different interferon preparations.

    Guido Antonelli;Maurizio Currenti;Ombretta Turriziani;Ferdinando Dianzani

  • Torquetenovirus: the human virome from bench to bedside

    D. Focosi;G. Antonelli;M. Pistello;F. Maggi

  • Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19

    Gabriella d'Ettorre;Giancarlo Ceccarelli;Massimiliano Marazzato;Giuseppe Campagna

  • Long-term results of therapy with interferon-alpha for type II essential mixed cryoglobulinemia

    Milvia Casato;Bruno Laganà;Guido Antonelli;Ferdinando Dianzani

  • Predictors of Long-Term Response to High-Dose Interferon Therapy in Type II Cryoglobulinemia Associated With Hepatitis C Virus Infection

    Milvia Casato;Vincent Agnello;Leopoldo P. Pucillo;Glenn B. Knight

  • Human Papillomaviruses and genital co-infections in gynaecological outpatients

    Rosita Verteramo;Alessandra Pierangeli;Emanuela Mancini;Ettore Calzolari

  • Detection and typing by molecular techniques of respiratory viruses in children hospitalized for acute respiratory infection in Rome, Italy.

    Alessandra Pierangeli;Massimo Gentile;Paola Di Marco;Paolo Pagnotti

  • Rhinovirus bronchiolitis and recurrent wheezing: 1-year follow-up

    F. Midulla;A. Pierangeli;G. Cangiano;E. Bonci

  • Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosis.

    Valentina Tomassini;Andrea Paolillo;Pierluigi Russo;Elisabetta Giugni

  • Neutralizing antibodies to recombinant alpha-interferon and response to therapy in chronic hepatitis C virus infection

    M Milella;G Antonelli;T Santantonio;M Currenti

  • Respiratory syncytial virus bronchiolitis, weather conditions and air pollution in an Italian urban area: An observational study.

    Raffaella Nenna;Melania Evangelisti;Antonella Frassanito;Carolina Scagnolari

  • Breakthrough during recombinant interferon alfa therapy in patients with chronic Hepatitis C virus infection: Prevalence, etiology, and management

    Luigi Roffi;Guido Colloredo Mels;Guido Antonelli;Giorgio Bellati

  • Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro.

    Nicola Clementi;Carolina Scagnolari;Antonella D’Amore;Fioretta Palombi

  • Probiotic supplementation promotes a reduction in T-cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART-treated HIV-1-positive patients.

    Gabriella d'Ettorre;Giacomo Rossi;Carolina Scagnolari;Mauro Andreotti

  • C-C chemokines, IL-16, and soluble antiviral factor activity are increased in cloned T cells from subjects with long-term nonprogressive HIV infection.

    Enrico Scala;Gianpiero D'Offizi;Rosamaria Rosso;Ombretta Turriziani

  • Dynamics of Persistent TT Virus Infection, as Determined in Patients Treated with Alpha Interferon for Concomitant Hepatitis C Virus Infection

    Fabrizio Maggi;Mauro Pistello;Marialinda Vatteroni;Silvano Presciuttini

  • Human OX40 tunes the function of regulatory T cells in tumor and nontumor areas of hepatitis C virus-infected liver tissue.

    Silvia Piconese;Eleonora Timperi;Ilenia Pacella;Valeria Schinzari

  • Torquetenovirus viremia kinetics after autologous stem cell transplantation are predictable and may serve as a surrogate marker of functional immune reconstitution

    Daniele Focosi;Fabrizio Maggi;Melania Albani;Lisa Macera

  • Rapid spread of the novel respiratory syncytial virus A ON1 genotype, central Italy, 2011 to 2013.

    A Pierangeli;D Trotta;C Scagnolari;M L Ferreri

Frequent Co-Authors

Mauro Pistello
Mauro Pistello University of Pisa
Fabrizio Maggi
Fabrizio Maggi University of Insubria
Vincenzo Vullo
Vincenzo Vullo Sapienza University of Rome
Maria Rosaria Capobianchi
Maria Rosaria Capobianchi National Institutes of Health
Gianluigi Giannelli
Gianluigi Giannelli Gastroenterology Hospital "Saverio de Bellis"
Claudio Maria Mastroianni
Claudio Maria Mastroianni Sapienza University of Rome
Massimo Clementi
Massimo Clementi Vita-Salute San Raffaele University
Massimo Andreoni
Massimo Andreoni University of Rome Tor Vergata
Enrico Girardi
Enrico Girardi Austrian Academy of Sciences
Adriano Lazzarin
Adriano Lazzarin Vita-Salute San Raffaele University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can open doors to diverse healthcare careers. Nursing programs, for example, complement Immunology studies by providing practical experience in patient care and disease management. Individuals without a nursing background might find online RN programs for non nurses in Florida an accessible entry point to the field.

Accelerated programs such as absn programs with high acceptance rates offer fast-tracked routes for students eager to advance in nursing. These programs blend foundational knowledge with clinical skills, making them attractive for those transitioning into healthcare roles connected to Immunology.

For those seeking licensed positions with shorter training periods, the best easiest lpn programs to get into provide a viable pathway. Licensed Practical Nurses often play crucial roles in immunization administration and patient monitoring, aligning well with Immunology-related work.

Further career advancement is possible through roles like nurse practitioners. The easiest nurse practitioner program options available online allow professionals to deepen their expertise, expanding their capabilities in specialized fields such as Immunology and infectious diseases.

Exploring these varied educational routes can enhance career prospects in immunology-related healthcare positions and build a strong foundation for future specialization.

Best Scientists Citing Guido Antonelli

Trending Scientists

Recently Published Articles